Cargando…
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956751/ https://www.ncbi.nlm.nih.gov/pubmed/35334007 http://dx.doi.org/10.1007/s12672-022-00481-6 |
| _version_ | 1784676627322503168 |
|---|---|
| author | Sasa, Keita Saito, Tsuyoshi Kurihara, Taisei Hasegawa, Nobuhiko Sano, Kei Kubota, Daisuke Akaike, Keisuke Okubo, Taketo Hayashi, Takuo Takagi, Tatsuya Yao, Takashi Ishijima, Muneaki Suehara, Yoshiyuki |
| author_facet | Sasa, Keita Saito, Tsuyoshi Kurihara, Taisei Hasegawa, Nobuhiko Sano, Kei Kubota, Daisuke Akaike, Keisuke Okubo, Taketo Hayashi, Takuo Takagi, Tatsuya Yao, Takashi Ishijima, Muneaki Suehara, Yoshiyuki |
| author_sort | Sasa, Keita |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8956751 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89567512022-04-08 Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma Sasa, Keita Saito, Tsuyoshi Kurihara, Taisei Hasegawa, Nobuhiko Sano, Kei Kubota, Daisuke Akaike, Keisuke Okubo, Taketo Hayashi, Takuo Takagi, Tatsuya Yao, Takashi Ishijima, Muneaki Suehara, Yoshiyuki Discov Oncol Retraction Note Springer US 2022-03-25 /pmc/articles/PMC8956751/ /pubmed/35334007 http://dx.doi.org/10.1007/s12672-022-00481-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Retraction Note Sasa, Keita Saito, Tsuyoshi Kurihara, Taisei Hasegawa, Nobuhiko Sano, Kei Kubota, Daisuke Akaike, Keisuke Okubo, Taketo Hayashi, Takuo Takagi, Tatsuya Yao, Takashi Ishijima, Muneaki Suehara, Yoshiyuki Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma |
| title | Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma |
| title_full | Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma |
| title_fullStr | Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma |
| title_full_unstemmed | Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma |
| title_short | Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma |
| title_sort | retraction note to: ire1α-xbp1 but not perk inhibition exerts anti-tumor activity in osteosarcoma |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956751/ https://www.ncbi.nlm.nih.gov/pubmed/35334007 http://dx.doi.org/10.1007/s12672-022-00481-6 |
| work_keys_str_mv | AT sasakeita retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT saitotsuyoshi retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT kuriharataisei retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT hasegawanobuhiko retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT sanokei retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT kubotadaisuke retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT akaikekeisuke retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT okubotaketo retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT hayashitakuo retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT takagitatsuya retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT yaotakashi retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT ishijimamuneaki retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma AT sueharayoshiyuki retractionnotetoire1axbp1butnotperkinhibitionexertsantitumoractivityinosteosarcoma |